WILLIAM SCHWIETERMAN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2010-11-12 William Schwieterman(7) 154,208 *
2011-02-18 William Schwieterman(6)
2012-11-19 William Schwieterman(6) 105,060 * Includes options to purchase 96,100 shares of common stock, which are exercisable on November 1, 2012 or within 60 days thereafter.

Data sourced from SEC filings. Last updated: 2026-02-03